Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Closes $1.1B BioSpin Acquisition

NEW YORK (GenomeWeb News) – Bruker BioSciences announced after the close of the market last night that it has completed its acquisition of Bruker BioSpin and has been renamed Bruker Corp.
Roughly 57.5 million shares of new, unregistered Bruker common stock worth around $624.9 million were issued for the stock component of the deal. Combined with the $388 million cash component of the deal, the total value of the acquisition is nearly $100 million more than when Bruker announced its intention to buy BioSpin in early December.
Following completion of the acquisition, Bruker will operate in two segments: the life science and analytical systems segment, and the international advanced superconductor segment.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.